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PENGETAHUAN, SIKAP DAN AMALAN DIABETES MELLITUS:  
KAJIAN PERBANDINGAN DI ANTARA PESAKIT MALAYSIA DAN 
EMIRATE ARAB BERSATU  
 
ABSTRAK 
     Diabetes melitus merupakan masalah kesihatan yang terjadi di serata  
dunia.  Prevalensnya berbeza-beza di pelbagai tempat di dunia. Diketahui bahawa 
pendidikan yang baik tentang diabetes adalah suatu kaedah berkesan untuk 
mengawal diabetes. Setengah kajian ke atas program pendidikan kesihatan yang 
berbeza, yang dijalankan di Malaysia dan juga di Emirate Arab Bersatu (UAE) 
menunjukkan bahawa secara umumnya pengetahuan tentang penyakit dan 
pengurusana diabetes di kedua-dua negara ini adalah kurang jika dibandingkan 
dengan negara-negara lain. Objektif utama kajian ini adalah untuk mengetahui 
perbezaan dalam tahap pengetahuan, sikap  dan amalan (KAP) pesakit diabetes dan 
juga kesannya (kawalan glisemia) di kalangan pesakit diabetes di klinik pesakit 
luar endokrin dan di pusat diabetes di antara  Malaysia dan UAE Kajian prospektif 
perbandingan telah dijalankan daripada September 2006 hingga Jun 2008. Seramai 
202 orang Pesakit Luar Klinik Diabetes daripada Hospital Pulau Pinang, Malaysia  
dan 201 orang Pesakit Luar Endokrin, Pusat Diabetes, Sheikh Khalifa Medical City 
di Abu Dhabi (UAE) terlibat dalam kajian ini. Pesakit yang memenuhi ciri-ciri 
yang dikehendaki telah  ditemubual secara individu dan secara sukarela mengisi 
boring soalselidik berhubungkait dengan pengetahuan mereka tentang diabetes, 
sikap mereka tentang penyakit dan amalan yang mereka lakukan dalam pengurusan 
XX 
 
penyakit yang telah divalidasikan,. Data tentang ciri-ciri demografi, sejarah 
perubatan, analisis urin dan darah yang terkini dan terapi drug semasa dicatat 
dalam borang khusus. Regresi logistik pelbagai digunakan untuk membandingkan 
perbezaan perkadaran di antara kedua-dua kumpulan berasaskan pakej statistik 
untuk sains sosial (SPSS) versi 12.0. Ujian Khi-kuasa dua, ANOVA post hoc dan 
ujian-t bebas digunakan untuk membandingkan purata bagi KAP, HbA1c dan 
kepekatan gula darah sewaktu puasa di antara dua kumpulan. Kajian ini 
menunjukkan secara signifikan responden-responden diabetes Malaysia lebih baik 
KAP daripada responden–responden UAE dengan purata skor  pengetahuan, sikap 
dan amalan adalah 25.6 ±3.34 berbanding  20.26 ±2.96, 4.29±1.17 berbanding 2.90 
±0.086 dan 4.25 ±1.33 berbanding 4.1 ±0.99 masing-masing (P <0.001). Kajian ini 
juga menunjukkan perbezaan dalam ciri-ciri sosial, faktor risiko, kekerapan 
kehadiran kelas pendidikan diabetes, sumber maklumat dan kawalan glisemia di 
antara pesakit diabetes di Malaysia dan UAE. Dalam usaha mengawal diabetes, 
disyorkan agar kerajaan Malaysia dan juga UAE dapat mengaplikasikan 
pengalaman negara lain, yang telah berjaya dengan program pendidikan kesihatan. 
Selain pengetahuan, sikap dan amalan pesakit juga penting kerana pengetahuan 
semata-mata tidak mampu memberi kesan terhadap kawalan glisemia atau 
mencegah terjadinya komplikasi yang signifikan.   
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KNOWLEDGE, ATTITUDE AND PRACTICE OF DIABETES 
MELLITUS: 
A COMPARATIVE STUDY BETWEEN MALAYSIAN AND THE 
UNITED ARAB EMIRATES PATIENTS 
 
ABSTRACT 
 
     Diabetes mellitus is an emerging health problem worldwide, the 
prevalence varies widely in different regions around the world. It is well known 
that good diabetes education is a cornerstone of diabetes control. Some studies of 
different health education programs in Malaysia and the United Arab Emirates 
(UAE) have shown that diabetics in these countries generally know less about the 
disease and its management than diabetics in other countries. The main objective 
of this study is to determine the differences in the levels of the knowledge, 
attitudes, and the practice (KAP) of diabetic patients and also the impact (glycemic 
control) at endocrine outpatient clinic and diabetes center, between Malaysia and 
the UAE. A comparative prospective study was conducted from September 2006 to 
June 2008. Two hundreds and two outpatients of Diabetic Clinic from Penang 
Hospital of Malaysia and 201 patients from Endocrine Outpatient's Clinic, Diabetic 
Center of Sheikh Khalifa Medical City in Abu-Dhabi (UAE) participated in this 
study. Patients who fulfilling the desired criteria were interviewed individually and 
voluntarily filled a validated questionnaire about their knowledge of diabetes, their 
attitudes toward the disease, and their disease management practices. Data on the 
XXII 
 
demographic characteristics, medical history, latest blood tests and urine analyses, 
and current drug therapies were collected in a specific data collection form. 
Multiple logistic regressions were used to compare the proportional differences 
between these two groups based on statistical package for the social sciences 
(SPSS) version 12.0. Chi-square test, ANOVA post hoc, and independent t-test 
were used to compare the means of KAP, HbA1c, and fasting blood sugar 
concentrations between the two groups. This study shows Malaysian diabetic 
respondents has significantly  better  KAP than the UAE respondents with mean 
scores of knowledge, attitude and practice were (25.6 ±3.34 vs. 20.26 ±2.96), 
(4.29±1.17 vs. 2.90 ±0.086) and (4.25 ±1.33 vs. 4.1 ±0.99) respectively (P <0.001). 
This study also reveals differences in the social characteristics, risk factors, 
frequency of attendance at the diabetes education class and the sources of 
information between Malaysian and the UAE patients. Achieving better diabetes 
control, and reducing the prevalence of the disease, it is suggested that Malaysian 
people and the UAE may benefit from the experiences of the each other and from 
other countries with specific health education programs. Attitudes and practices of 
patients are also important beside their knowledge, as knowledge alone cannot 
affect glycemic control a lot, or cannot significantly prevents the incidence of 
complications.     
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CHAPTER 1 
INTRODUCTION  
1.1 Background 
      Diabetes mellitus is an emerging health problem worldwide, the 
prevalence of diabetes varies widely in different regions around the world, 
but there is a significant increase in the prevalence of this chronic disease in 
developing and developed countries. The prevalence of diabetes in adults is 
expected to rise by about 170% in developing countries, whereas developed 
countries are expected to see an increase in diabetes prevalence of 42% 
(King et al., 1998). 
United Arab Emirates (UAE) had positioned as the 2
nd
 country with highest 
prevalence of diabetes in the world (18.7%) (IDF, 2009). This may refer to 
the rapid economic development has been associated with incredible 
changes in lifestyle towards the westernized pattern reflected by changes in 
nutrition, less physical activity, and tendency to increased obesity.  
      Whereas, Malaysia has ranked the 10
th
 position with (13.8%) of the top 
10 of the highest countries with diabetes prevalence in 2009 (IDF, 2009). 
While it was 11.6% in 2006 and 6.3% in 1986 (Third National Health and 
Morbidity Survey, 2006). The increases of prevalence in Malaysia probably 
related to the increases in the size of the aging population, increased 
urbanization, lifestyle changes, dietary changes, and improvements in the 
diagnostic testing (Rampal et al., 2009).  This concern about the explosion in 
the prevalence of diabetes around the world is compounded by the 
difficulties involved with the diabetes control. Generally, diabeties patients 
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cannot easily achieve the glycemic control goals, despite all the advances in 
diabetes treatment. This inability to obtain glycemic control goals may refers 
to many factors such as; lacking of sufficient knowledge about the diabetes, 
poor attitude and poor diabetes management practices.      
   Patients with diabetes mellitus are often lacking for sufficient knowledge 
about their disease and thus frequently will have poor self-management 
skills. The patients' ability to understand and to carry out their individual 
treatment regimen is critical to the diabetes mellitus glycemic control.   
Unfortunately, the gap between what diabetic patients understood about the 
disease and what they do to control it, is still increasing in Malaysia and in 
the UAE. Many factors contribute in the widening of this gap; one of these 
factors could be due to the lacking in number of research in this field 
especially in the Asian countries. Therefore, this study was designed to 
detect and to compare the differences in the KAP levels of the diabetic 
patients in two different sites. Malaysia and the UAE, were have deficiencies 
in outlining of some practical steps in the improving knowledge, awareness, 
behaviors and attitudes toward better quality of life of the both populations.  
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1.2 Diabetes prevalence and cost worldwide   
      According to the estimation of the United Nations Fund Population of 
East Asian and Pacific Affairs, around 284.6 million people worldwide in 
2009 were estimated to have diabetes, with over 438.4 million predicted to 
have the condition by 2030 (IFD, 2009). However, these figures may 
significantly underestimate the extent of this problem. Up to 50% of those 
who were diabetic are thought to remain undiagnosed and therefore 
untreated. There is likely to be a substantial increase in the number of 
individuals presenting with diabetes associated microvascular and 
macrovascular complications. 
    The number of people with diabetes is expected to increase at an alarming 
rate in the coming decades. As in 1985, it was expected that 30 million 
people worldwide had diabetes, whereas in 2000 the figure had risen to over 
than 150 million people with diabetes around the world (Zaini, 2000).  
    The cost of treatment has also increases dramatically and destructive to 
the human, social and economic effects. The largest costs of diabetes 
worldwide are its devastating effects on families and national economies 
(International Diabetes Federation, 2007). 
     A diabetes cost includes direct costs such as; hospital stays, outpatient 
visits, drugs and supplies. And indirect costs such as; loss of productivity, 
absenteeism, disability, and early mortality (American Diabetes Association, 
2008).    
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1.2.1 Diabetes in Malaysia 
      Malaysia is the heart of central Southeast of Asia, The total population of 
Malaysia is over 28,609,844 Population, Malaysia (2010). Approximately 
half (49.4%) of them are females. Ethnic groups in Malaysia include, 
Malays (50.3%), Chinese (23.8%), Non-Malay indigenous population 
(11.0%) and Indians (7.1%) (August, 2008) (Department of Statistics - 
Malaysia, 2008). The Malaysian Government expenditures on health are 2% 
of the gross domestic product United Nations Population Fund (UNFPA, 
2005). Diabetes is a growing concern in Malaysia. It has been observed that 
the number of people with diabetes in Malaysia is increasing and that 
complications rates and associated diseases amongst diabetics are extremely 
high. The prevalence of diabetes mellitus in this country has also steadily 
increased over the years, from an estimated 0.65% in 1960 up to 2% in 1982 
(Lim, 1991). 
    In the First National Health and Morbidity Survey (NHMS I) conced in 
1986, the prevalence of diabetes mellitus was estimated to be 6.3%. This 
prevalence had increased by 1996, and in the Second National Health and 
Morbidity Survey showed that the national prevalence of diabetes in 
Malaysia was 8.3%, and it is continued to increase (Second National Health 
and Morbidity Surveys, 1996). 
      In the (NHMS III), the prevalence was 11.6%, based on the prevalence 
among adults aged 30 years and above, it has been estimated that there were 
700,000 to 900,000 persons with diabetes in 1999 (Zanariah et al., 2006). 
     At this time, near 1.2 million people in Malaysia have diabetes 
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(Malaysian Diabetes Association, 2009). Moreover, the prevalence of 
undiagnosed diabetes is 2.5%. Unfortunately, more than half of the people 
are not aware that they have the disease (Ooyub et al., 2004).  
     The prevalence of diabetes mellitus by Malaysian states varies 
geographically. The highest observed prevalence of known diabetes was 
recorded in Penang and Selangor (7.3%), whereas the highest prevalence of 
undiagnosed diabetes was observed in Negeri Sembilan (4.1%), Penang 
(3.5%), and Melaka (3.1%). For the two categories of diabetes mellitus, 
urban areas recorded significantly higher prevalence compared to the rural 
areas (Bakri, 2007). From the World Health Organization report about 
mortality by country for 2006, diabetes is the 6
th
 leading cause of death in 
Malaysia, accounting for 4% of deaths annually (World Health 
Organization, 2006).  While, the department of statistics Malaysia, reported 
diabetes mellitus is the 8
th
 cause of death in Malaysia with 1.8% of all death 
in 2007 (Statistics on causes of death, 2007). 
     In 2010, Malaysia is ranking 10
th
 with diabetes all over the world (IDF, 
2009). This increase in the prevalence of diabetes also parallels a dramatic 
increase in the medical costs. Statistics from the Malaysia Ministry of Health 
(MOH) records showed that the number of admissions to government 
hospitals in Peninsular Malaysia for diabetes mellitus increased from 19,629 
cases in 1991 to 30,661 cases in 2001, an increase of 56% over a span of 10 
years, Moreover, mortality due to diabetes has also increased from 254 
deaths in 1991 to 380 deaths in 2001, an increase of 50% (Ooyub et al., 
2004).  
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       In Selangor in 2002, a previous study showed that the provider’s cost 
per diabetes patient per year was RM 185.97, whereas the direct cost per 
diabetes patient visit was RM 53.03 (Nabila, 2002).  
     A big portion of the Health Ministry's budget on medicine has been spent 
on drugs for (hypertension, diabetes, and high cholesterol). The Health 
Minister Datuk Seri Dr. Chua Soi Lek said that, since the beginning of the 
2008 year, RM180 million, or 20% out of its annual RM 900 million budget 
was spent on such drugs (Chua, 2007). 
    From the Malaysian statistics on medicines, the drug therapy of diabetes 
is one of the top expenditures in Malaysia, of the total amount spent on 
medications, the most was spent on medicines for the treatment of blood 
pressure, cholesterol, and diabetes, which accounted for 63% of the 
expenditures for the top 40 utilized medicines and for 18.5% of all medicinal 
expenditures for 2005 (2.24 billion) (Goh, 2005). 
    In another previous study, the most commonly used medications in 
Malaysia during 2005 were the anti-diabetic medications (3.6% of the 
population), glibenclamide was used in (1.3% of the population) while, 
metformin was used in (1.2%) as the most commonly used drugs. Moreover, 
in 2005, diabetic drugs were among the top 30 most widely used therapeutic 
drugs as defined by dose per 1000 population per day (Lim et al., 2005).   
 
1.2.2 Diabetes in the United Arab Emirates  
        The United Arab Emirates is a union of seven Sovereign Sheikhdoms. 
It is located in the Middle East, with an estimated population of 4,621,399 
(2005). Local national make up around 20% of the total populations, and the 
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majority of the populations (nationals and non-nationals) in the UAE is male 
(67.7%), whereas females represent 32.3% (UAE Ministry of Economy, 
2007). Diabetes mellitus was the fifth leading cause of disability, mortality, 
and morbidity in the UAE in 2006, whereas it was the seventh leading cause 
of death in 2002 (World Health Organization, 2006).  
     Deaths attributed to diabetes accounted for (2–3%) of all deaths in the 
past 10 years. Almost all deaths were reported among persons aged 45 years 
and older. A recent joint WHO/UAE study showed that the prevalence of 
diabetes is approximately 17%, which could serve as a preliminary baseline 
on which to build a solid database to guide the national plan, The UAE 
government expenditure on health is about 3.3% of its gross domestic 
product (WHO report, 2002- 2006; UAE -Ministry of Health report, 2006). 
 The Ministry of Health of the United Arab Emirates studied the prevalence 
of diabetes mellitus in the country from 1998 to 2000, The study was 
conducted on 6,609 men and women, including 2,363 nationals and 4,246 
expatriates, it was reported that the overall percentage of people with 
diabetes was (19.6%), in the UAE citizen group the percentage was (24%), 
whereas in the expatriates it was (17.4%), highlighting the higher prevalence 
in the native UAE population (El-Sharkawy, 2004). In a study in 2006, the 
prevalence of diabetes was (20%), and it was higher among the UAE 
citizens (25%) than in the expatriates (13-19%) depending on the country of 
origin (Malik et al., 2006). The prevalence of diabetes rose with age to a 
maximum of 40% after age 55 years old (Malik et al., 2006).  
     The most likely reason for that huge increase in diabetes among the UAE 
population is due to extraordinary social changes resulting in the adoption of 
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an increasingly western lifestyle that has resulted in dramatic changes in diet 
and in nutrition, more sedentary lifestyle shifting, and an increasing 
prevalence of the obesity and increasing smoking habits among adults. 
These socioeconomic changes were believed to be responsible for the 
explosion of diabetes across the region (Abduelkarem et al., 2008). 
     The direct cost of diabetes mellitus treatment was 300 million dollars per 
year in 2007; this cost is for approximately 350,000 of the UAE citizens who 
have been diagnosed with diabetes mellitus (10.9%) of the population of the 
UAE, The cost is nearly 900 dollars per person per year (Tadmori, 2007).  
     In Al-Ain, the second largest city in the Abu Dhabi Emirate, diabetes 
accounted for 6% of all general medical admissions to the hospital over a 
five year period between 1980 and 1984 (Omar et al., 1985). 
 
1.3 Literature Review 
1.3.1 Demographic data  
1.3.1 (a) Diabetes and age 
         Diabetes is a disease that affects people of all ages. However, the 
incidence rates of type I diabetes, type II diabetes or/and other forms of this 
disorder vary from one age group to another. The risk for developing type II 
diabetes increases with the age and most are diagnosed after the age of 45 
years. Moreover, the number of obese children has risen dramatically over 
the years, as has the number of children and teens diagnosed with type II 
diabetes (Malik et al., 2007). The Centers for Disease Control and 
Prevention, the United States of America reported that from 1980 through 
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2005, the age-adjusted prevalence of diagnosed diabetes increased among all 
race groups examined (CDCP, 2007). 
   From the Third National Health and Morbidity Survey III, Malaysia, there 
was 2% prevalence of diabetes with age range 18-19 years old. While, there 
was an alarming prevalence among 50-64 years old which ranging between 
20.8% -26.2% (Letchuman et al., 2006). 
     In a published study in 2005, the highest percentage of diabetes patients 
were aged (50-59) years old (Mafauzy, 2005).  In another study, 35% of 
patients who had uncontrolled type II diabetes were aged > 50 years old 
(Adliah et al., 2004). In the UAE, the prevalence of diabetes rose with age to 
a maximum of 40% after the age of 55 years old (Malik et al., 2006). The 
latest study published in 2009 found that among 7683 respondents aged ≥30 
years (Rampal et al., 2009). 
 
1.3.1 (b) Diabetes onset 
        The longer the period of the disease, the patient’s glycemic levels tends 
to be elevated more, and this will increase the risk of complications. This 
does not mean that the knowledge about the disease and diabetic 
management practices of patients who have had diabetes for a long time are 
better than those who have been newly diagnosed or who have only been 
diagnosed with diabetes for a short period of time.  
     In one study done in Malaysia, 39% of the uncontrolled hyperglycemic 
patients had been diagnosed with type II diabetes mellitus for more than 10 
years (Adliah et al., 2004).  
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     One study done in the UAE indicated that there was no significant 
difference between the time since diagnosis and changes in glycosylated 
hemoglobin levels over a period of two years (Andrews et al., 2002).  
 
1.3.1 (c) Diabetes and gender 
      As for gender distribution, a previous report suggests that the female 
dominated in the number of patients with diabetes. Females were about 10% 
more to have diabetes than men (International Diabetes Federation, 2006). 
      In the Second and Third National Health and Morbidity Surveys of 
Malaysia has reported that, no significant differences were found between 
the gender and knowing or undiagnosed diabetes (Third National Health and 
Morbidity Survey, 2006). One study found that 55% of diabetes patients 
were females and 45% were males (Yun et al., 2007).  
Whereas another previous study was found that 61.4% of diabetes patients 
were females and 38.6% were males (Sulaiman et al., 2004).  
      In addition, the complications incidences were vary between the male 
and female. National Diabetes Institute reported that diabetic macrovascular 
complications including ischemic heart disease and stroke were higher 
among Malays and Indian females (Mafauzy, 2005).  
     In another published study in Malaysia, females were twice as likely as 
males to have diabetes, and the familial association was greater (Mustafa, 
1985). One study published in 2001 reported that out of 300 diabetes 
patients, 51% were males and 49% were females (Abdullah et al., 2001). 
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     In 1995, another previous study with 322 subjects reported that the 
diabetes gender prevalence was 11% in males and 7% in females (El 
Mugamer, 1995).  
     In the UAE, the percentage of male with diabetes is slightly higher than 
that of female. In a study done in Rashid Hospital, Dubai, in 2005-2006, of 
4,713 diabetes patients who visited the diabetes clinic, 56.7% were female 
(Statistical Analysis Section-Department of Health and Medical Services, 
Dubai, 2007).  
    At the same hospital, the number of in-patients hospitalized due to 
diabetes complications was 538, 56.4% of whom were male. Finally, a 
previous study found, 51.8% of the 2,548 patients enrolled in the study were 
male (Khattab et al., 2007). 
 
1.3.1. (d) Diabetes and race  
       The NHMS II mentioned that the prevalence of known diabetes among 
Indians (11.5%) was significantly higher than that of other races (Second 
National Health and Morbidity Survey, 1996). Malaysian Indians are at 
greater risk of being diabetes compared to the other ethnic groups with the 
estimated prevalence ranging from 3.5% -16% (Ooyub et al., 2006). 
      In a previous study describe the diagnosing of diabetes among patients in 
Malaysia according to the races and means of age, it was found that the 
mean of age in Malays were, 56.7 years; Chinese, 62.7 years; Indians, 57.3 
years; and in other ethnic group 76.0 years. The complications were also 
different for different races (Chan, 2005).   
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     Another study published in Medical Journal of Malaysia found that 
diabetic macrovascular complications including ischemic heart disease, 
stroke, and peripheral vascular disease were higher in Malay and Indian 
females (Mustafa, 2004).  
     From the NHMS III, Indians have the highest prevalence of diabetic 
complications (19.9%), followed by Malays (11.9%) and Chinese (11.4%) 
(Third National Health and Morbidity Survey, 2006). In a recent study done 
in Malaysia, Indians had higher risk of having diabetes by 10% than the 
Chinese (Rampal et al., 2009).  
     In the UAE, there seems to be a genetic predisposition to diabetes among 
the UAE nationals, and statistics show that they have a higher prevalence 
than other nationalities within the UAE (Barakat, 2007). 
    Increasing the risk of diabetes may be due to intra-familial marriages 
between the Emirates because 92% marry their relatives (Amin, 2009).                         
    El-Sharkawy, 2007 stated that the percentage of local diabetic was higher 
(24%) than the expatriates (17.4%) in the UAE community 
    In another previous study, out of 300 diabetes patients, 58% was Emirati, 
and 42% were from other nationalities (Abdullah et al., 2001).  
    In Rashid Hospital, Dubai in the period of (2005-2006), 4,713 diabetes 
patients who were visiting the diabetes clinic, 68.7% were from Emirati 
nationality (Department of Health and Medical Services UAE, 2007).     
    Another study reported that 66% of the diabetics patients were Emirati 
population (Khattab et al., 2007). 
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1.3.2 Social characteristics  
1.3.2 (a) Diabetes and educational level 
    Most of the previous studies done in Malaysia and the UAE on the 
educational level of diabetes patients have reported a lower educational level 
of diabetes patients than those of non-diabetic. High percentage of illiteracy 
and primary school were among diabetes patients. A previous study done in 
Kelantan, Malaysia reported that education level was low in diabetes 
patients, with 25.4% having no formal education, 42.1% having a primary 
school education, 30.7% having a secondary school education, and only 
1.8% having attended college/university (Sulaiman et al., 2004). In another 
study, 128 diabetes patients, 77% had less than 6 years of formal schooling 
(Tan, 2004). In yet another study done in 1997 in Kuantan, Malaysia, the 
more educated group of patients had better glucose control than the less-
educated group (Adibah et al., 1998). 
    Finally a study reported a significant difference in the glycemic control in 
patients with different educational status (Ismail et al., 2000).      
    In a study on patients in the UAE 512 female diabetes patients, 32% did 
not have formal education, 11% had primary education, 28% secondary 
education, and 29% post-secondary education (Carter et al., 2004). 
    In another study in the UAE, there were 172 illiterate patients out of 300 
(57%) respondents, 18 self-educated patients (6%), 38 patients with primary 
school education (13%), 45 patients with secondary school education (15%), 
and 27 patients with post-secondary education (9%) (Abdullah et al., 2001). 
    In yet another study, out of 219 diabetic patients, 58% were uneducated 
(Bakir et al., 2004). 
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 Finally a study reported out of 513 diabetic patients, 62.8% were illiterate, 
19.6% had completed primary school, 11.9% had completed secondary 
school, and 5.7% had completed university. Of these patients, 62.4% were in 
poor control of their diabetes (Al Maskari, 2004).  
 
1.3.2 (b) Diabetes and occupation  
    The Second National Health and Morbidity Survey, 1996 in Malaysia 
reported that the prevalence of diabetes decreased with increasing status of 
diabetic patients in term occupation; the unemployed had a high prevalence 
of known (12.8%) and undiagnosed (3.6%) diabetes, the pensioners had a 
high prevalence of known (12%) and undiagnosed (4%) diabetes (Second 
National Health and Morbidity Survey, 1996). This trend may have been due 
to an increased prevalence among older patients, who tend to be unemployed 
or retired people.  
    In a previous study, there was not a big difference in the level of glycemic 
control between the patients who were sedentary or non-sedentary (72% vs. 
69.8 %), (Adibah et al., 1998).  
    In another pervious study done in the UAE it was found that, 52.7% of 
patients in Dubai were employed, with 20% of all patients having a 
controlled HbA1c or less than 7% (Khattab et al., 2007).  
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1.3.2 (c) Diabetes and marital status 
       In one previous study done in Malaysia, with 400 patients reported a 
significant association between blood glucose control and marital status (P 
<0.05). Patients who were unmarried had a 4-fold higher risk of having poor 
blood glucose control compared to married patients (Adibah et al., 1998). 
 
 
1.3.3 Risk factors 
 
       Many risk factors predispose patients to developing diabetes. Besides 
genetics, there is sufficient evidence to show that one of the main factors 
influencing the explosion of diabetes in modern times is lifestyle related 
changes that lead to obesity and its related co-morbidities. 
 
1.3.3 (a) Diabetes and family history 
       Positive family history is a risk factor for diabetes. In a study published 
in the Malaysian Journal for Medical Science, 62 out of 211 Malaysian 
diabetic patients (29%) had a positive family history of diabetes mellitus 
(Eid et al., 2003). In a study done in the UAE, 121 diabetes patients out of 
300 (40%) had a family history of diabetes (Abdullah et al., 2001). 
    In another study, 54.3% of 513 diabetic patients had a family history of 
diabetes mellitus (Al Maskari et al., 2007).   
 
1.3.3 (b) Diabetes and obesity  
       The prevalence of obesity is rising to epidemic proportions worldwide. 
Being overweight or obese seriously increases an individual’s risk of 
developing other health problems such as type II diabetes. The means by 
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which excessive body fat causes type II diabetes is not clearly defined, but it 
appears that excess fat increases insulin resistance, raising blood glucose 
levels and the likelihood of developing diabetes (International Diabetes 
Federation, 2006). 
     In the Second National Health Morbidity Survey in 1996 reported that 
20.1% of males were overweight and 4.0% were obese, whereas 21.4% of 
females were overweight and 7.6% obese. Amongst those with diabetes 
mellitus, 18.8% were either obese or overweight (Second National Health 
Morbidity Survey, 1996). 
     In a study in Kelantan, 38.4% of diabetic patients were either obese or 
overweight compared to 24.1% of those with normal glucose tolerance 
(Mafauzy, 2006). In a countrywide survey that was conducted in 1997, 43-
52% was either overweight or obese, in Malay and Indian females (Mustafa, 
2004). 
     Obesity is a point of concern in the UAE population. A study of national 
nutrition performed by the UAE Ministry of Health in 2000 revealed that 
33% of married women in the UAE were overweight and 38% were obese, 
whereas for married men, 40.3% were overweight, but only 15.8% were 
obese. A study done in the UAE showed that around 20% of the population 
suffers from obesity (United Arab Emirates Ministry of Health, 2001).  
     In a study published in the Diabetes Research and Clinical Practice 
Journal, obesity was common in nearly all ethnic groups in the UAE. 
Approximately three-quarters of all diabetes patients of this previous study 
were either obese or overweight (Malik et al., 2006). 
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1.3.3 (c) Diabetes and smoking 
     Although there is no direct relationship between tobacco smoking and the 
development of diabetes or the ability to achieve glycemic control, smoking 
can aggravate many of the problems that people with diabetes already face, 
such as heart and cardiovascular disease. Moreover, it can also make 
managing diabetes more difficult for those who already have it (Cleveland 
Clinic, 2008). Generally, from many statistics in Malaysia and the UAE, 
more than 20% of the population smokes.  
     In Malaysia, about half of men smoke, and 30% of men in the UAE are 
smokers (World Health Organization, 2006). A previous study done in 
Malaysia was reported that 15.9% of the respondents were smokers.   
Moreover, same study found that smoking had no significant effects on 
glycemic control in type II diabetic patients (Eid et al., 2004). 
       In a previous study done in Dubai, UAE, 24.7% of the diabetic patients 
were smokers (Khattab et al., 2007). In a published previous study in 
Sharjah, UAE  it was reported that (52%) of male diabetes patients were 
heavy smokers (Abduelkarem and Sackville, 2008).  
 
1.3.4 Diabetes and source of information 
     A study published in the Patient Education and Counseling Journal 
(PECJ) in 2007 about the knowledge of diabetes patients in northern 
Malaysia reported that most (54%) of the information about diabetes and its 
management that diabetic patients knew was obtained from health-care 
professionals such as medical officers, pharmacists, and nurses, followed by 
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friends and relatives (17%) and books and magazines were 9.16% (Yun et 
al., 2007).  
      In a study published in the Eastern Mediterranean Health Journal 
(EMHJ) about the source of information for diabetes patients in the UAE, 
results showed that the most common sources of patient information about 
diabetes were nurses and doctors (59%), and then written and electronic 
media (40%). Ineffective sources of information about diabetes were 
pharmacists with 0% (Abdullah et al., 2001).  
 
1.3.5 Glycemic control 
     Glycemic control is the maintenance of the blood glucose levels at or 
slightly above the “normal” blood glucose level for the average of non-
diabetic individual. The goal of glycemic control is to keep the blood 
glucose levels of diabetics as close to a “normal” level as possible. Much 
evidence suggests that many of the long-term complications of diabetes, 
especially the microvascular complications, result from many years of 
hyperglycemia (elevated levels of glucose in the blood). Good glycemic 
control, in the sense of a "target" for treatment, has become an important 
goal of diabetes care. There are many tests used for monitoring blood 
glucose level; the most important tests are Hemoglobin A1c and fasting 
blood glucose (University of Michigan, 2008; American Diabetes 
Association, 2008).  
     The Hemoglobin A1C test provides an index
 
of a patient's average blood 
glucose level during the past 2-3 months
 
and is considered the most 
objective and reliable measure
 
of long-term metabolic control. The benefit of 
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this monitoring is to evaluate the effects of lifestyle and drug therapy in their 
ability to control the disease. Many studies have been performed to 
investigate the effects of monitoring blood glucose level and therapy plans 
on the ability of patients to maintain good glycemic control. The Diabetes 
Control and
 
Complications Trial establishes that maintaining HbA1c levels
 
as close as possible to the normal range, results in considerable reductions
 
in 
the long-term health complications (Delamater, 2006).  
    In the UK, a total of 4,075 diabetic patients who maintained target
 
glycemic levels decreased markedly over 9 years of follow-up by 8% of 
monotherapy with diet, 42% of insulin treatment, and 24% of sulfonylurea 
therapy, achieved target fasting plasma glucose levels, and achieved target 
HbA1c
 
levels by 9% of monotherapy with diet, 28% of insulin treatment, and 
24% of sulfonylurea therapy (Turner et al., 1999).  
     In a study published in Malaysia showed that only 41% of the patients 
had HbA1c less than 7% and only 18% had FPG less than 6.1 mmol/L 
(Mafauzy, 2005). In another study in Malaysia, only 20% of the patients had 
HbA1c less than 7% and 11% had FPG less than 6.7 mmol/L (Mafauzy, 
2006).  
    In a study was performed in outpatient diabetes clinics from 2001 to 2002, 
211 patients were observed, Abnormal fasting plasma glucose and high 
glycated hemoglobin levels were observed in 60% and 73% of type 2 
diabetic patients, respectively. Glycated hemoglobin levels of 28% of the 
subjects were (less than 7%), (36%) were between (7 - 9%), and (36%) were 
(more than 9%). The worst glycemic control was observed in Malay 
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patients, as HbA1C levels of Malays and Non-Malays subjects were 
8.7±2.3%) and (7.7±1.7%), respectively (Eid et al., 2004).  
    In a previous study done in Malaysia in 2004, the mean of HbA1c level 
was (9.9 ± 2.82) and (85.7%) of the patients had HbA1c levels (above 7%) 
(Sulaiman et al., 2004). In another previous study, the glycemic control was 
optimal in 28% of the patients HbA1c (less than 6.5%), and fair in 34% 
whereas HbA1c is between (6.5-7.5%), and poor in 38% where HbA1c is 
(more than 7.5%) (Wong et al., 2004).  
    In another study in Malaysia, the overall glycemic control for 926 patients 
with diabetes diagnosed before 40 years of age was poor, with an average 
HbA1c of 8.6% and with 61.1% of the patients with an HbA1c greater than 
8% (Ismail et al., 2000). A study done in the UAE included 513 diabetic 
patients, of whom 62.4% were found to have poor glycemic control based on 
HbA1c >7% (Al Maskari et al., 2007). 
    In another previous study, the proportion of subjects with diagnosed 
diabetes mellitus who achieved the internationally recognized target for 
HbA1c of <7% was 33.3% (Saadi et al., 2007). In study done in the UAE, 
only 31% had an HbA1c of less than 7% (Al Kaabi et al., 2008).  
 
1.3.6 Diabetes and chronic complications 
        Chronic complications have conventionally been divided into two 
categories: Microvascular complications, which include nephropathy, 
neuropathy, and retinopathy, and Macrovascular complications, which 
include disorders of the cardiovascular, stroke, and peripheral vascular 
systems (American Association of Clinical Endocrinologists, 2007).   
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1.3.6 (a) Microvascular complications 
1.3.6. a (i) Nephropathy  
         Diabetes is the leading cause of kidney failure in the developed 
world, and it accounts for approximately 35% to 40% of new cases each 
year. In the United States, 10% of all people with diabetes develop kidney 
disease (International Diabetes Federation 2003; Chaplin, 2005).  
Diabetic nephropathy is now the primary cause of end-stage renal failure in 
Sarawak, Malaysia (Wong, 2005). 
     Data from the Malaysia National Renal Registry showed an increasing 
number of diabetic patients who required dialysis, from 40% in 1999 to 44% 
in 2000 and 45% in 2001. In 2002, it was reported that 47% of all new 
patients for dialysis had end-stage renal failure due to diabetes. Moreover, 
other results from this registry showed that 2,236 (28%) out of 7,984 
diabetes patients had one positive microalbumin test (Ooyub et al., 2004). 
    In a study the nephropathy complications were albuminuria (22.9%) and 
microalbuminuria (20.4%) (Mafauzy, 2005).  
    In a later study, the rate of albuminuria was 15.7%, and the rate of 
microalbuminuria was 6.6% (Mafauzy, 2006). 
    In another study, the rate of microalbuminuria complication in 1997 was 
52% among diabetes patients (Mustafa, 2004). A previous study found that 
48% of the diabetic patients in a public primary care clinic had proteinuria 
and advocated screening and treatment of proteinuria in diabetics in the 
primary care setting to retard the progress of nephropathy (Wong, 2005). 
 In yet another study the prevalence of macroalbuminuria and 
microalbuminuria were 15.7% and 39.7%, respectively (Knog, 2006). 
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      In the UAE the prevalence rate for nephropathy was 40.8% among 
diabetic patients (Saadi et al., 2007).  
     The prevalence rate of glycemic control is defined as the maintenance of 
blood glucose levels at or slightly above “normal” blood glucose levels for 
the average non-diabetic individual. The goal of glycemic control is to keep 
the blood glucose levels of diabetics as close to a “normal” level as possible; 
microalbuminuria was considerably higher (61%) among diabetic patients in 
the UAE (Al Maskari et al., 2008). 
Diabetic nephropathy was the cause of end-stage renal disease in 
approximately 25-35% of patients on hemodialysis in the UAE (Yahya, 
1998). 
 
1.3.6. a (ii) Retinopathy 
          Diabetes is the leading cause of blindness and visual impairment in 
adults in developed countries. Each year, 15,000 to 39,000 people lose their 
sight because of diabetes. The incidence of blindness is 25 times higher in 
people with diabetes than in the general population (International Diabetes 
Federation, 2006). 
          In 2002, the Malaysia National Registry reported that 2,138 diabetic 
cases or 34% of diabetic patients had some forms of retinopathy (Ooyub et 
al., 2004). In another study it was found that the prevalence of eye 
complications among diabetes patients was 53% having retinopathy and 1% 
with developed blindness (Mustafa, 2004).  
       The Second National Health and Morbidity Survey (NHMS II) showed 
that the most common complication associated with diabetics was vision 
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problems (42.2-53.9%). In two other studies the percentages of the subjects 
with retinopathy who were Malays were 11.1% and Indian and 23.5%, 
respectively (Mafauzy, 2005; Mafauzy, 2006).  
      In two different studies in Malaysia, diabetic retinopathy has been 
reported to be as prevalent as 51.6% -59.2% among diabetic patients 
(Tajunisah et al., 2006; Hien et al., 2006). In another study conducted in the 
UAE, the prevalence rates for retinopathy were (19-54.2%) among patients 
with diabetes. The disease was more common among the male than female 
(24.2% vs. 13.9%), and the prevalence increased with increasing age and 
with disease duration (Al Maskari et al., 2004). In another study Type I 
diabetes was highly significantly contributing risk factor for type I (38.3% 
vs. 16.4%) for type II (Saadi et al., 2007).  
 
1.3.6. a (iii) Neuropathy, foot complications and amputation  
           Foot complications result from a complex interplay of ischemia, 
ulceration, infection and diabetic Charcot’s joint. Approximately 50% of all 
those who have diabetes for over 25 years have evidence of nerve damage in 
their feet. Nerve damage can lead to loss of feeling, muscular weakness, 
amputation, and impotence (Malaysia Diabetes Association, 2005). 
     Diabetic foot complications pose a substantial problem in the Malaysian 
diabetic population. They are a major source of morbidity and a leading 
cause of hospital bed occupancy, and they account for substantial health care 
costs and resources. Foot complications have been found to account for 12% 
of all diabetic hospital admissions, which in turn make up 17% of all 
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hospital admissions at Hospital Kuala Lumpur, Malaysia (Malaysian 
Ministry of Health and Academy of Medicine, 2004).   
      The prevalence of neuropathy complications was reported to be 58% in 
1997 in diabetes patients (Mustafa, 2004). 
     The Second National Health and Morbidity Survey reported that a 
commonly perceived complication associated with diabetic condition among 
known diabetics was numbness (34.8-42.1%) (Second National Health and 
Morbidity Survey, 1996). Two previous studies showed that the prevalence 
of neuropathy complications in the diabetic study population was 30.1% and 
19% respectively (Mafauzy, 2005; Mafauzy, 2006). In another study 
peripheral neuropathy was reported in 39% out of a study population of 513 
diabetic patients in Al-Ain, UAE (Al Maskari, 2004).  
      Also upon neurological examination, 26/60 UAE diabetes patients (43%) 
had clinical signs of polyneuropathy and a positive neuropathy deficit score 
(NDS) (Baba et al., 1998). The prevalence rate for neuropathy in the UAE 
was 34.7% (Saadi et al., 2007). Nerve damage combined with peripheral 
vascular disease makes diabetes the most common cause of amputation that 
is not a result of an accident. People with diabetes are 15 to 40 times more 
likely to require a lower-limb amputation compared to the general 
population. Diabetic foot disease has become a major medical, social and 
economic challenge worldwide. While 5% of patients with diabetes have a 
history of ulceration, the cumulative lifetime incidence is 15%, and, 20% of 
those with peripheral vascular disease will require amputation. In developing 
countries, it has been estimated that foot problems may account for as much 
as 40% of available healthcare resources. Extensive epidemiological surveys 
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have indicated that between 40% and 70% of all lower extremity 
amputations are related to diabetes (International Diabetes Federation, 
2005). 
     In Malaysia in 1997, 2% of diabetes patients had had amputations 
(Mustafa, 2004). It was shown that 66.5% of patients who underwent 
amputation during the period from 2003 to 2005 in Kelantan Hospital were 
diabetic and these amputations were related to the diabetic foot conditions. 
In addition, 59.3% of these patients were less than 60 years old (Yousf et al., 
2007). 
 
1.3.6 (b) Macrovascular Complications 
1.3.6. b (i) Cardiovascular diseases  
      People with diabetes are two to four times more likely to develop 
cardiovascular diseases. The risk of mortality for cardiovascular disease is 
40 times greater than in people without diabetes. The risk of peripheral 
vascular disease (PVD) in diabetics is four times higher (International 
Diabetes Federation, 2005; American Diabetes Association, 2003).  
    From the Second National Health and Morbidity Survey, 10% of the 
known diabetics perceived that they suffered slow wound healing, stroke, 
and cardiovascular diseases associated with their diabetic condition (Second 
National Health and Morbidity Survey, 1996).  
    A study published in 2003 mentioned that the prevalence of diabetes 
mellitus amongst hospitalized patients with stroke was 55.2%, which is 
higher than that reported in other international studies (Hamidon et al., 
2003). Other results of this study included data showing that diabetes was a 
